RVL Pharmaceuticals gains on exploring strategic alternatives
05/07/2023 12:28
** Shares of RVL Pharmaceuticals RVLP.O up 3.5% at $0.57
premarket
** Company says it has been considering certain strategic
alternatives, including discussions to acquire "specific
potential counterparty" in an all-stock transaction
** RVL says it is also in business development discussions
with other parties
** Company's shares down ~51% YTD
(Reporting by Yamini Kalia in Bengaluru)
((Yamini.Kalia@thomsonreuters.com))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius